Novoray Corporation

SHSE:688300 Lagerbericht

Marktkapitalisierung: CN¥9.9b

Novoray Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Novoray wird ein jährliches Gewinn- und Umsatzwachstum von 27.3% bzw. 22.7% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 27% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.6% betragen.

Wichtige Informationen

27.3%

Wachstumsrate der Gewinne

27.0%

EPS-Wachstumsrate

Chemicals Gewinnwachstum39.5%
Wachstumsrate der Einnahmen22.7%
Zukünftige Eigenkapitalrendite19.6%
Analystenabdeckung

Low

Zuletzt aktualisiert23 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Recent updates

Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

Oct 18
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher

These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

Oct 16
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely

What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

Sep 26
What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Aug 20
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

Jul 29
Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business

What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Jul 13
What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You

Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

Jun 19
Why Novoray Corporation (SHSE:688300) Could Be Worth Watching

If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

May 13
If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity

Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Apr 23
Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?

Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 01
Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Mar 28
Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts

Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

Mar 01
Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%

When Should You Buy Novoray Corporation (SHSE:688300)?

Feb 27
When Should You Buy Novoray Corporation (SHSE:688300)?

Gewinn- und Umsatzwachstumsprognosen

SHSE:688300 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CNY Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20261,461420N/A3585
12/31/20251,182329N/A2825
12/31/2024935245N/A1765
9/30/2024895234167248N/A
6/30/2024841218164236N/A
3/31/2024769197137189N/A
12/31/2023712174194247N/A
9/30/2023685182139203N/A
6/30/2023625169156248N/A
3/31/2023630174130277N/A
12/31/202266218886241N/A
9/30/202265717524213N/A
6/30/2022686186-47161N/A
3/31/2022663179-64117N/A
12/31/2021625173-55153N/A
9/30/2021581169-94117N/A
6/30/2021522147-42135N/A
3/31/2021473130-57104N/A
12/31/2020404111-3490N/A
9/30/2020367921998N/A
6/30/2020341822995N/A
3/31/20203217827100N/A
12/31/2019315752081N/A
9/30/2019298694397N/A
6/30/2019292672370N/A
3/31/2019277602953N/A
12/31/2018278583056N/A
9/30/201826454834N/A
6/30/201824950N/A12N/A
3/31/201823046N/A9N/A
12/31/201721142N/A6N/A
9/30/201719341N/A17N/A
6/30/201717639N/A27N/A
3/31/201716536N/A22N/A
12/31/201615433N/A18N/A
9/30/201614327N/AN/AN/A
6/30/201613220N/A16N/A
3/31/201612719N/A12N/A
12/31/201512218N/A7N/A
9/30/201512119N/A3N/A
6/30/201513220N/A9N/A
3/31/201513119N/A16N/A
12/31/201412519N/A17N/A
12/31/201312014N/A28N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 688300Das prognostizierte Gewinnwachstum (27.3% pro Jahr) liegt über der Sparquote (2.8%).

Ertrag vs. Markt: 688300Die Erträge des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (26.2% pro Jahr).

Hohe Wachstumserträge: 688300Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: 688300Die Einnahmen des Unternehmens (22.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (13.8% pro Jahr).

Hohe Wachstumseinnahmen: 688300Die Einnahmen des Unternehmens (22.7% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 688300Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.6%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y